DUSP6 and neoplasm: These experiments demonstrate a lineage specific effect of DUSP6/MKP-3, with the phosphatase acting as a tumour suppressor in myeloid cells, but as an essential mediator of malignancy in pre-B cells and suggest that this undue reliance on negative feedback regulators of ERK activity may present a vulnerability and reveal novel drug targets in pre-B cell malignancy.